PepperLime Health Acquisition Corp. (PEPLU) Prices $150M IPO

PepperLime Health Acquisition Corp. announced the pricing of its $150 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “PEPLU” Friday, October 15.

The new SPAC intends to partner with health and wellness platforms, with an emphasis on physical health, mental health, sexual wellness, women’s health and sleep related health, that are either technology-enabled or are primed for technological innovation. PepperLime Health is led by Chairman of the Board and CEO Ramzi Haidamus, CFO Eran Pilovsky, President Frank Ferrari, and EVP Maurice Op de Beek.

Total SPAC deal count for 2021 year-to-date is now 470. This offering is expected to close on Tuesday, October 19.

Oppenheimer & Co. is acting as the sole book running manager for the offering. Freshfields Bruckhaus Deringer US LLP is serving as Issuer’s Counsel with DLA Piper LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.